Tag: Aspirin
Aspirin Use Not Tied to Clinical Outcomes in Nonobstructive CAD
Statin use linked to reduced risk for major adverse cardiovascular events in individuals with nonobstructive coronary artery disease
USPSTF: Do Not Start Low-Dose Aspirin to Prevent CVD in 60+
For those aged 40 to 59 years, the decision to initiate low-dose aspirin for primary prevention of CVD should be individualized
Early Aspirin Cuts In-Hospital Mortality With Moderate COVID-19
Largest benefits seen for patients older than 60 years with no increased risk for hemorrhagic complications
Questions Remain About Safety of Aspirin Cessation in Older Adults
Findings inconclusive for subgroup analysis looking at safety of ceasing regular aspirin use without a clinical indication after age 70 years
Daily Aspirin Does Not Prevent Recurrence of Breast Cancer
Compared with placebo, daily aspirin did not improve invasive disease-free survival in patients with high-risk, HER2-negative breast cancer
Link Between Analgesics, Incident Tinnitus Explored in Women
No increased risk for tinnitus seen with low-dose aspirin, but increase seen with moderate-dose aspirin for those younger than 60 years, NSAIDS, acetaminophen
Aspirin Underutilized for Preeclampsia Prevention
Findings reported among women at high risk due to prepregnancy diabetes, obesity, and/or chronic hypertension
Preventive Aspirin Should Be Based on Benefit, Not Age
Authors urge primary care physicians to make case-by-case basis decisions based on benefit-to-risk
Aspirin Use Tied to Incident Heart Failure in At-Risk Adults
Aspirin use associated with increased risk for incident heart failure among individuals with or without a history of cardiovascular disease
USPSTF Recommends Aspirin for Those at High Risk for Preeclampsia
Low-dose aspirin has substantial benefit for reducing risk for preeclampsia, preterm birth, IUGR, perinatal mortality